M-VAC protocol

Known as: M-VAC regimen, MVAC protocol, CDDP/DOX/MTX/VBL 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The potential of medium-voltage dc (MVDC) grids in various applications has been under investigation by different researchers. In… (More)
  • figure 1
  • figure 2
  • figure 3
  • table I
  • table II
Is this relevant?
2015
2015
BACKGROUND The efficacy of neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (BCa) was established primarily with… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
This paper describes the design and implementation of the first functional medium-voltage impedance measurement unit capable of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Fig. 1 – Relationships among the intrinsic subtypes identified in bladder cancer and the intrinsic subtypes of breast cancer… (More)
  • figure 1
  • table 1
Is this relevant?
2010
2010
This paper describes an innovative Medium Voltage Direct Current electrical grid system (MVDC) for wind farms, based on… (More)
  • figure 1
  • figure 2
  • figure 3
  • table I
  • figure 5
Is this relevant?
2008
2008
BACKGROUND Neoadjuvant cisplatin-based chemotherapy improves survival in muscle-invasive urothelial cancer, with MVAC… (More)
Is this relevant?
2006
2006
OBJECTIVES To report the long-term follow-up of patients with locally advanced bladder cancer treated with either adjuvant… (More)
Is this relevant?
2005
2005
BACKGROUND The majority of patients with advanced urothelial cancer are elderly, but data regarding this specific age group are… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2004
2004
A randomised phase III trial of MVAC (methotrexate, vincristine, doxorubicin, cisplatin) vs gemcitabine and cisplatin (GC) (G… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
1998
Review
1998
Gemcitabine (GEMZAR) is a novel nucleoside analogue with activity in a range of preclinical models both in vitro and in vivo. It… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?